TrinityPoint Wealth’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,420
Closed -$203K 347
2024
Q3
$203K Sell
3,420
-150
-4% -$8.57K 0.03% 317
2024
Q2
$200K Sell
3,570
-70
-2% -$3.92K 0.03% 301
2024
Q1
$213K Sell
3,640
-250
-6% -$14.1K 0.04% 291
2023
Q4
$210K Buy
+3,890
New +$190K 0.04% 285
2023
Q3
Sell
-3,979
Closed -$225K 296
2023
Q2
$225K Hold
3,979
0.04% 253
2023
Q1
$215K Buy
3,979
+13
+0.3% +$692 0.05% 254
2022
Q4
$208K Buy
+3,966
New +$201K 0.05% 259
2022
Q3
Sell
-3,986
Closed -$201K 287
2022
Q2
$201K Sell
3,986
-1,342
-25% -$73.1K 0.04% 263
2022
Q1
$325K Sell
5,328
-545
-9% -$32.5K 0.06% 235
2021
Q4
$387K Sell
5,873
-85
-1% -$5.44K 0.07% 214
2021
Q3
$374K Buy
+5,958
New +$380K 0.07% 212

Other funds holding IHI

TrinityPoint Wealth's IHI Position: Q4 2024 in Review

TrinityPoint Wealth sold out of iShares US Medical Devices ETF (IHI) in Q4 2024, closing a stake of 3,420 shares — an estimated $203K sold.

TrinityPoint Wealth first reported a position in IHI in Q3 2021 and held it in 11 quarters. The position peaked at $387K in Q4 2021. 564 funds tracked by Wall St. Rank hold IHI as of Q4 2024.

  • TrinityPoint Wealth reported no remaining iShares US Medical Devices ETF position as of Q4 2024 after selling out during the quarter.
  • TrinityPoint Wealth sold 3,420 iShares US Medical Devices ETF shares in Q4 2024, an estimated $203K.
  • TrinityPoint Wealth first reported a position in iShares US Medical Devices ETF in Q3 2021 and held it in 11 quarters.
  • TrinityPoint Wealth's iShares US Medical Devices ETF position peaked at $387K in Q4 2021.
  • 564 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q4 2024.

Based on TrinityPoint Wealth's 13F filing for Q4 2024, filed 14 Feb 2025.